Abstract:Flowchart of methods employed for in vitro metabolism assessment in multiple fish species of regulatory relevance. NADPH = reduced nicotinamide adenine dinucleotide phosphate; GSH = glutathione; UDPGA = uridine diphosphate glucuronic acid; PAPS = 3′‐phosphoadenosine‐5′‐phosphosulfate; std = standard; OECD TG = Organisation for Economic Co‐operation and Development test guideline. Bioaccumulation predictions can be substantially improved by combining in vitro metabolic rate measurements derived from rainbow trout hepatocytes and/or hepatic S9 fractions with quantitative structure–activity relationship (QSAR) modeling approaches. Compared with in vivo testing guidelines Organisation for Economic Co‐operation and Development (OECD) 305 and Office of Chemical Safety and Pollution Prevention (OCSPP; an office of the US Environmental Protection Agency) 850.1730, the recently adopted OECD test guidelines 319A and 319B are in vitro approaches that have the potential to provide a time‐ and cost‐efficient, humane solution, reducing animal use while addressing uncertainties in bioaccumulation across species. The present study compares the hepatic clearance of the S9 subcellular fraction of rainbow trout, bluegill, common carp, fathead minnow, and largemouth bass, discerning potential differences in metabolism between different warm‐ and cold‐water species. With refinements to the in vitro metabolic S9 assay for high‐throughput analysis, we measured in vitro clearance rates of seven chemicals crossing multiple classes of chemistry and modes of action. We confirmed that data from rainbow trout liver S9 fraction metabolic rates can be utilized to predict rainbow trout bioconcentration factors using an in vitro to in vivo extrapolation model, as intended in the OECD 319B applicability domain per the bioaccumulation prediction. Also, we determined that OECD 319B can be applied to other species, modified according to their habitat, adaptations to feeding behavior, and environmental conditions (e.g., temperature). Once toxicokinetics for each species is better understood and appropriate models are developed, this method can be an excellent tool to determine hepatic clearance and potential bioaccumulation across species. The present study could be leveraged prior to or in place of initiating in vivo bioconcentration studies, thus optimizing selection of appropriate fish species. Environ Toxicol Chem 2024;00:1–16. © 2024 SETAC

A Comparison of In Vitro Metabolic Clearance of Various Regulatory Fish Species Using Hepatic S9 Fractions

Comparative Pharmaceutical Metabolism by Rainbow Trout (oncorhynchus Mykiss) Liver S9 Fractions

Approach for extrapolating in vitro metabolism data to refine bioconcentration factor estimates

Predicting Hepatic Clearance of Psychotropic Drugs in Isolated Perfused Fish Livers Using a Combination of Two <i>In Vitro</i> Assays br

Concentration dependence of in vitro biotransformation rates of hydrophobic organic sunscreen agents in rainbow trout S9 fractions: Implications for bioaccumulation assessment

A Comparative Study of Phase I and II Hepatic Microsomal Biotransformation of Phenol in Three Species of Salmonidae: Hydroquinone, Catechol, and Phenylglucuronide Formation

PFAS Biotransformation Pathways: A Species Comparison Study

The Tissue‐Specific Eco‐Exposome: Differential Pharmaceutical Bioaccumulation and Disposition in Fish among Trophic Positions

Organ-specific biotransformation in salmonids: Insight into intrinsic enzyme activity and biotransformation of three micropollutants

In Vitro Predictions of Acute Fish Toxicity for Development of Sustainable Crop Protection Products

Comparative in vitro hepatic clearances of commonly used antidepressants, antipsychotics, and anti-inflammatory agents in rainbow trout liver S9 fractions

In vitro approach to refine bioconcentration and biotransformation predictions of organic persistent pollutants using cell lines

Exploring Alternatives for Marine Toxicity Testing: Initial Evaluation of Fish Embryo and Mysid Tests

Investigating the bioaccumulation potential of anionic organic compounds using a permanent rainbow trout liver cell line

High-throughput Assessment of Oxidative Respiration in Fish Embryos: Advancing Adverse Outcome Pathways for Mitochondrial Dysfunction

Comparison of toxicity values across zebrafish early life stages and mammalian studies: Implications for chemical testing

Comparing Transcriptomic Points of Departure to Apical Effect Concentrations For Larval Fathead Minnow Exposed to Chemicals with Four Different Modes Of Action

Intrinsic clearance of xenobiotic chemicals by liver microsomes: Assessment of trophic magnification potentials.

Daphnids Can Safeguard the Use of Alternative Bioassays to the Acute Fish Toxicity Test: A Focus on Neurotoxicity

Metabolomic‐Based Comparison of Daphnia magna and Japanese Medaka Responses After Exposure to Acetaminophen, Diclofenac, and Ibuprofen

Uptake/depuration kinetics, bioaccumulation potential and metabolic transformation of a complex pharmaceutical mixture in zebrafish ( Danio rerio )